Non Toxic Memory Enhancement Prl-8-53 Nootropic Supplements CAS 51352-88-6

Delivery Time:3-5 days
Certification:ISO9001

Non Toxic Memory Enhancement Prl-8-53 Nootropic Supplements CAS 51352-88-6

Product Description

PRL-8-53 is a nootropic research compound first synthesized in the 1970’s by Dr Nikolaus Hansl while working at Creighton University,he single study involving humans showed PRL-8-53 improved word recollection scores both 24 and 96 hours after initial memorization. Given the low amount of evidence available for this nootropic, we thought it relevant to reference a journal article in which the creator discusses the compound and numerous other human trials it was used in.

Basic Information

Product Name	PRL-8-53	Other Name	PRL-8-53
Appearance	white powder	CAS No.	51352-87-5
Purity	99%HPLC	M.W	319.82578
Melting Point		M.F	C18H22ClNO2
Loss On Drying	0.17%	Boiling point
Structure

Function

1. Enhance cognition and memory formation

2. Anxiolytic properties

3. Anti-depressive effect

4. Treatment of Alzheimer's and Parkinson's disease

5. Increase coordination

6. Improves mood

7. Help fight fatigue

8. Prevent oxidation within the brain

9. Treat alcohol related brain damage

10. Prevent caffeine withdrawal symptoms

COA

Item	Inspection Standard	Results
Appearance	Off white solid powder	Conform
Identification	Conform with NMR	Conforms
Melting Point	149-152°C	150-151°C
Loss on Drying	≤0.50%	0.21%
Residue on ignition	≤1.0%	0.32%
Purity(HPLC)	≥99%	99.2%
Heavy metals	NMT 20PPM	Conforms
Conclusion:This product by inspection accords with the in-house standard

PRL-8-53 is considered as a nootropic agent that remains to be a research compound to date. It was developed and patented by Dr. Nikolaus Hansl during the 1970s while he was working at Creighton University. The acronym PRL came from its previous patent holder Pacific Research Labs. Please note that there is very little published clinical research done to evaluate the effects and safety of this chemical agent. These published studies are even undertaken by the creator himself which might present bias towards its efficiency. For this reason, it is advised that one exercise precautions with this research nootropic compound. Despite the lack of supporting literature however, anecdotal reports appear very favorable.

Related Products

Carphedon

Pramiracetam

Sunifiram

Coluracetam

Pirespa

Noopept

Adrafinil

Unifiram

NSI-189 freebase

NSI-189 phosphate

Tianeptine

Tianeptine sodium

Tianeptine sulphate

Prl-8-53

5a hydroxy laxogenin